MAYNF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Mayne Pharma Group Ltd

Watchlist Manager

Watchlist

Price: 1.65 USD

Market Cap: $140.4m

	Mayne Pharma Group Ltd OTC:MAYNF	AU
N	NewAmsterdam Pharma Company NV DUS:KH6	NL
	Teekay Corp NYSE:TK	BM
L	LeddarTech Holdings Inc. NASDAQ:LDTC	CA
	Cobram Estate Olives Ltd ASX:CBO	AU
	Oxford Instruments PLC F:OX3	UK
T	Telecom Italia SpA XHAM:TQI	IT
N	NewAmsterdam Pharma Company NV F:KH6	NL
Y	Yatra Online Ltd NSE:YATRA	IN
	Kin and Carta PLC F:9L2	UK

Profitability Summary

Mayne Pharma Group Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

63%

Strong 3Y Average Gross Margin

59%

Gross Margin is Increasing

40% > 63%

Negative Operating Margin

-7%

Negative 3Y Average Operating Margin

-35%

Operating Margin is Increasing

-230% > -7%

Negative Net Margin

-20%

Negative 3Y Average Net Margin

-24%

Declining Net Margin

96% > -20%

Negative Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-28%

Free Cash Flow Margin is Increasing

-465% > 0%

Negative ROE

-21%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-11%

ROIC is Increasing

-14% > -4%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.